Get our free Sclero e-Newsletter!
Media News by Date |
|
| December 2009 | |
| Bacteria linked to autoimmune disease. Researchers at the University of Connecticut Health Center in Farmington said their animal study found a unique type of lipid known as phosphorylated dihydroceramides produced by some bacteria -- in this case by human bacteria commonly found in the mouth called porphyromas gingivali. UPI.com. 11/25/09. (Also see: Autoimmunity) | |
| Permanently cold teenager braces herself as big chill begins. Her condition (Raynaud's and systemic scleroderma), which was diagnosed three years ago, intensifies in the winter, leaving her in constant pain. Ben Spencer. DailyRecord.co.uk. 12/12/09. | |
| Chronic Illness Survivor Reveals Ways To Beat Holiday Stress. Let friends and family plan and host the holiday happenings. You only have so much energy and it must be conserved, because the result of exceeding our already compromised energy allotment can be as we know from past experience both physically and emotionally ugly. Jackie ONeal. Ground Report. 12/12/09. (Also see: Coping) | |
| Brief Training In Meditation May Help In Pain Management. Living with pain is stressful, but a surprisingly short investment of time in mental training can help you cope. A new study examining the perception of pain and the effects of various mental training techniques has found that relatively short and simple mindfulness meditation training can have a significant positive effect on pain management. Medical News Today. 11/11/09. (Also see: Pain Management) | |
| FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension (PAH). FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension. (Business Wire) Pfizer. 11/20/09. (Also see: PAH Treatments) | |
| High-resolution CT (HRCT) useful for monitoring response of sclerodermal lung disease to treatment. HRCT scans provide an objective method of assessing changes in both inflammation and fibrosis in the lungs of patients with interstitial lung disease. They therefore provide a useful complement to measured changes in lung physiology. Will Boggs, MD. (Reuters) RF Magazine. 11/25/09. (Also see: Pulmonary Fibrosis) |
|
|||||||||||||||||||
|
|||||||||||||||||||
| Go to Scleroderma Media News: November 2009 | |||||||||||||||||||
|
|||||||||||||||||||
